Gamida Cell ltd
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL (NCT05296525) | Gamida Cell ltd | 2022-07-05 |
| Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies (NCT04260698) | Gamida Cell ltd | 2020-07-08 |
Track Gamida Cell ltd automatically
Every clearance here is in the API, with alerts when new ones post.